Clinical Research Directory
Browse clinical research sites, groups, and studies.
Study on the Dynamic Changes of Metabolic Biomarkers and Their Prognostic Relationship in Ovarian Cancer
Sponsor: Women's Hospital School Of Medicine Zhejiang University
Summary
Ovarian cancer is a highly lethal gynecological malignancy, often diagnosed at an advanced stage, with high rates of recurrence within 1-2 years after frontline treatment. Current guidelines recommend monitoring tumor markers CA125 and HE4 for disease progression, but these markers may not detect recurrence or disease progression when their levels are below the detection limit. Therefore, there is a need to identify new prognostic biomarkers and monitor their dynamic changes for effective risk stratification and personalized treatment in patients with ovarian cancer
Key Details
Gender
FEMALE
Age Range
18 Years - 75 Years
Study Type
OBSERVATIONAL
Enrollment
100
Start Date
2023-10-26
Completion Date
2027-09-10
Last Updated
2025-07-17
Healthy Volunteers
Not specified
Conditions
Interventions
No intervention
No intervention
Locations (1)
Women's Hospital School of Medicine Zhejiang University
Hangzhou, Zhejiang, China